-
1
-
-
0035498662
-
Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: A population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix
-
Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer 2001;92:2471-83.
-
(2001)
Cancer
, vol.92
, pp. 2471-2483
-
-
Alfsen, G.C.1
Kristensen, G.B.2
Skovlund, E.3
Pettersen, E.O.4
Abeler, V.M.5
-
2
-
-
0037303234
-
Prognostic factors in neuroendocrine small cell cervical carcinoma: A multivariate analysis
-
Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003;97:568-74.
-
(2003)
Cancer
, vol.97
, pp. 568-574
-
-
Chan, J.K.1
Loizzi, V.2
Burger, R.A.3
Rutgers, J.4
Monk, B.J.5
-
3
-
-
0030008046
-
Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix
-
Sevin BU, Method MW, Nadji M, Lu Y, Averette HA. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 1996;77:1489-93.
-
(1996)
Cancer
, vol.77
, pp. 1489-1493
-
-
Sevin, B.U.1
Method, M.W.2
Nadji, M.3
Lu, Y.4
Averette, H.A.5
-
4
-
-
0031813132
-
Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy
-
Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 1998; 83:712-8.
-
(1998)
Cancer
, vol.83
, pp. 712-718
-
-
Chang, T.C.1
Lai, C.H.2
Tseng, C.J.3
Hsueh, S.4
Huang, K.G.5
Chou, H.H.6
-
5
-
-
0027957446
-
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
-
Abeler VM, Holm R, Nesland JM, Kjørstad KE. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 1994;73:672-7.
-
(1994)
Cancer
, vol.73
, pp. 672-677
-
-
Abeler, V.M.1
Holm, R.2
Nesland, J.M.3
Kjørstad, K.E.4
-
6
-
-
0026493942
-
Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide
-
Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW, et al. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 1992;47:62-5.
-
(1992)
Gynecol Oncol
, vol.47
, pp. 62-65
-
-
Morris, M.1
Gershenson, D.M.2
Eifel, P.3
Silva, E.G.4
Mitchell, M.F.5
Burke, T.W.6
-
7
-
-
0026087722
-
Small-cell neuroendocrine carcinoma of the cervix. A human papilloma-virus type 18-associated cancer
-
Stoler MH, Mills SE, Gersell DJ, Walker AN. Small-cell neuroendocrine carcinoma of the cervix. A human papilloma-virus type 18-associated cancer. Am J Surg Pathol 1991;15: 28-32.
-
(1991)
Am J Surg Pathol
, vol.15
, pp. 28-32
-
-
Stoler, M.H.1
Mills, S.E.2
Gersell, D.J.3
Walker, A.N.4
-
8
-
-
0035056218
-
Multimodality therapy in early-stage neuroendo-crine carcinoma of the uterine cervix
-
Boruta DM, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Multimodality therapy in early-stage neuroendo-crine carcinoma of the uterine cervix. Gynecol Oncol 2001; 81:82-7.
-
(2001)
Gynecol Oncol
, vol.81
, pp. 82-87
-
-
Boruta, D.M.1
Schorge, J.O.2
Duska, L.A.3
Crum, C.P.4
Castrillon, D.H.5
Sheets, E.E.6
-
9
-
-
0142058022
-
Small-cell carcinoma of the cervix: Fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy
-
Hoskins PJ, Swenerton KD, Pike JA, Lim P, Aquino-Parsons C, Wong F, et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 2003;21: 3495-501.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3495-3501
-
-
Hoskins, P.J.1
Swenerton, K.D.2
Pike, J.A.3
Lim, P.4
Aquino-Parsons, C.5
Wong, F.6
-
10
-
-
14744280487
-
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival
-
Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 2005;103:1258-64.
-
(2005)
Cancer
, vol.103
, pp. 1258-1264
-
-
Sherman, M.E.1
Wang, S.S.2
Carreon, J.3
Devesa, S.S.4
-
11
-
-
1242287067
-
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000
-
Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa SS. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-44.
-
(2004)
Cancer
, vol.100
, pp. 1035-1044
-
-
Wang, S.S.1
Sherman, M.E.2
Hildesheim, A.3
Lacey Jr, J.V.4
Devesa, S.S.5
-
12
-
-
1542398694
-
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01
-
Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22: 872-80.
-
(2004)
J Clin Oncol
, vol.22
, pp. 872-880
-
-
Eifel, P.J.1
Winter, K.2
Morris, M.3
Levenback, C.4
Grigsby, P.W.5
Cooper, J.6
-
13
-
-
0033561259
-
-
Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma [published erratum appears in N Engl J Med 1999;341:708]. N Engl J Med 1999;340:1154-61.
-
Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma [published erratum appears in N Engl J Med 1999;341:708]. N Engl J Med 1999;340:1154-61.
-
-
-
-
14
-
-
0033993937
-
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
-
Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1606-1613
-
-
Peters, W.A.1
Liu, P.Y.2
Barrett, R.J.3
Stock, R.J.4
Monk, B.J.5
Berek, J.S.6
-
15
-
-
34447562948
-
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study
-
Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25: 2804-10.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2804-2810
-
-
Rose, P.G.1
Ali, S.2
Watkins, E.3
Thigpen, J.T.4
Deppe, G.5
Clarke-Pearson, D.L.6
-
16
-
-
0032895783
-
Randomized comparison of fluorou-racil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
-
Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorou-racil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1339-1348
-
-
Whitney, C.W.1
Sause, W.2
Bundy, B.N.3
Malfetano, J.H.4
Hannigan, E.V.5
Fowler Jr, W.C.6
-
17
-
-
84949727120
-
-
NCI Issues Clinical Announcement on Cervical Cancer:, Available at:, Retrieved October 30, 2007
-
NCI Issues Clinical Announcement on Cervical Cancer: Chemotherapy Plus Radiation Improves Survival. Available at: http://www.nih.gov/news/pr/feb99/nci- 22.htm. Retrieved October 30, 2007.
-
Chemotherapy Plus Radiation Improves Survival
-
-
-
18
-
-
34347209985
-
Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: Results of a population-based cohort study
-
Pearcey R, Miao Q, Kong W, Zhang-Salomons J, Mackillop WJ. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study. J Clin Oncol 2007;25:2383-8.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2383-2388
-
-
Pearcey, R.1
Miao, Q.2
Kong, W.3
Zhang-Salomons, J.4
Mackillop, W.J.5
-
19
-
-
66749093311
-
-
Surveillance, Epidemiology, and End Results (SEER) Program web site. Data quality. Available at: http://seer.cancer.gov/ about. Retrieved May 6, 2005.
-
Surveillance, Epidemiology, and End Results (SEER) Program web site. Data quality. Available at: http://seer.cancer.gov/ about. Retrieved May 6, 2005.
-
-
-
-
20
-
-
66749189472
-
-
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Public-Use, Nov 2004 Sub (1973-2003 varying). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2006, based on the November 2005 submission.
-
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Public-Use, Nov 2004 Sub (1973-2003 varying). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2006, based on the November 2005 submission.
-
-
-
-
21
-
-
33644518674
-
Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiolog-ical studies
-
International Collaboration of Epidemiological Studies of Cervical CancerAppleby P
-
International Collaboration of Epidemiological Studies of Cervical CancerAppleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiolog-ical studies. Int J Cancer 2006;118:1481-95.
-
(2006)
Int J Cancer
, vol.118
, pp. 1481-1495
-
-
Beral, V.1
Berrington de Gonzalez, A.2
Colin, D.3
Franceschi, S.4
-
22
-
-
0035112607
-
Associations between smoking and adeno-carcinomas and squamous cell carcinomas of the uterine cervix (United States)
-
Lacey JV, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, et al. Associations between smoking and adeno-carcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 2001;12: 153-61.
-
(2001)
Cancer Causes Control
, vol.12
, pp. 153-161
-
-
Lacey, J.V.1
Frisch, M.2
Brinton, L.A.3
Abbas, F.M.4
Barnes, W.A.5
Gravitt, P.E.6
-
23
-
-
0344196967
-
Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case-control study
-
Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003;14:805-14.
-
(2003)
Cancer Causes Control
, vol.14
, pp. 805-814
-
-
Plummer, M.1
Herrero, R.2
Franceschi, S.3
Meijer, C.J.4
Snijders, P.5
Bosch, F.X.6
-
24
-
-
0025336958
-
Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers
-
Hildesheim A, Reeves WC, Brinton LA, Lavery C, Brenes M, De La Guardia ME, et al. Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers. Int J Cancer 1990;45:860-4.
-
(1990)
Int J Cancer
, vol.45
, pp. 860-864
-
-
Hildesheim, A.1
Reeves, W.C.2
Brinton, L.A.3
Lavery, C.4
Brenes, M.5
De La Guardia, M.E.6
-
25
-
-
0022492561
-
Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study
-
La Vecchia C, Decarli A, Fasoli M, Franceschi S, Gentile A, Negri E, et al. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. Br J Cancer 1986;54:311-7.
-
(1986)
Br J Cancer
, vol.54
, pp. 311-317
-
-
La Vecchia, C.1
Decarli, A.2
Fasoli, M.3
Franceschi, S.4
Gentile, A.5
Negri, E.6
-
26
-
-
17344385282
-
Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix
-
Lacey JV, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000;77:149-54.
-
(2000)
Gynecol Oncol
, vol.77
, pp. 149-154
-
-
Lacey, J.V.1
Brinton, L.A.2
Barnes, W.A.3
Gravitt, P.E.4
Greenberg, M.D.5
Hadjimichael, O.C.6
-
27
-
-
0023819068
-
Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma
-
Sheets EE, Berman ML, Hrountas CK, Liao SY, DiSaia PJ. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 1988;71:10-4.
-
(1988)
Obstet Gynecol
, vol.71
, pp. 10-14
-
-
Sheets, E.E.1
Berman, M.L.2
Hrountas, C.K.3
Liao, S.Y.4
DiSaia, P.J.5
-
28
-
-
0022641899
-
Prospective evaluation of risk of cervical cancer after cytological evidence of human papil-loma virus infection
-
Mitchell H, Drake M, Medley G. Prospective evaluation of risk of cervical cancer after cytological evidence of human papil-loma virus infection. Lancet 1986;1:573-5.
-
(1986)
Lancet
, vol.1
, pp. 573-575
-
-
Mitchell, H.1
Drake, M.2
Medley, G.3
-
29
-
-
0023080299
-
Human papillomaviruses and genital cancer
-
Pfister H. Human papillomaviruses and genital cancer. Adv Cancer Res 1987;48:113-47.
-
(1987)
Adv Cancer Res
, vol.48
, pp. 113-147
-
-
Pfister, H.1
-
31
-
-
0026533756
-
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind
-
Chan SY, Ho L, Ong CK, Chow V, Drescher B, Dü rst M, et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992;66:2057-66.
-
(1992)
J Virol
, vol.66
, pp. 2057-2066
-
-
Chan, S.Y.1
Ho, L.2
Ong, C.K.3
Chow, V.4
Drescher, B.5
Dü rst, M.6
-
32
-
-
0027376056
-
Evolution of human papillo-mavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups
-
Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, et al. Evolution of human papillo-mavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 1993;67:6424-31.
-
(1993)
J Virol
, vol.67
, pp. 6424-6431
-
-
Ong, C.K.1
Chan, S.Y.2
Campo, M.S.3
Fujinaga, K.4
Mavromara-Nazos, P.5
Labropoulou, V.6
-
33
-
-
0031052028
-
Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective
-
Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72.
-
(1997)
J Virol
, vol.71
, pp. 2463-2472
-
-
Yamada, T.1
Manos, M.M.2
Peto, J.3
Greer, C.E.4
Munoz, N.5
Bosch, F.X.6
-
34
-
-
0035812307
-
Asian-American variants of human papillomavirus 16 and risk for cervical cancer: A case-control study
-
Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-30.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1325-1330
-
-
Berumen, J.1
Ordonez, R.M.2
Lazcano, E.3
Salmeron, J.4
Galvan, S.C.5
Estrada, R.A.6
-
35
-
-
10744221855
-
Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix
-
Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003;63: 7215-20.
-
(2003)
Cancer Res
, vol.63
, pp. 7215-7220
-
-
Burk, R.D.1
Terai, M.2
Gravitt, P.E.3
Brinton, L.A.4
Kurman, R.J.5
Barnes, W.A.6
-
36
-
-
0034759704
-
Predictors of outcome in small cell carcinoma of the cervix-a case series
-
Straughn JM, Richter HE, Conner MG, Meleth S, Barnes MN. Predictors of outcome in small cell carcinoma of the cervix-a case series. Gynecol Oncol 2001;83:216-20.
-
(2001)
Gynecol Oncol
, vol.83
, pp. 216-220
-
-
Straughn, J.M.1
Richter, H.E.2
Conner, M.G.3
Meleth, S.4
Barnes, M.N.5
-
37
-
-
0028840564
-
Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: A possible role for type 18
-
Rose BR, Thompson CH, Simpson JM, Jarret CS, Elliott PM, Tatersall MH, et al. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol 1995;173:1461-8.
-
(1995)
Am J Obstet Gynecol
, vol.173
, pp. 1461-1468
-
-
Rose, B.R.1
Thompson, C.H.2
Simpson, J.M.3
Jarret, C.S.4
Elliott, P.M.5
Tatersall, M.H.6
|